New Test May Improve Treatment Of Kidney Disease

September 16, 1997

Why some patients with kidney diseases respond well to certain medications and others do not has continued to stump physicians. With no means to test the medications besides trial and error, finding the right treatment is often a frustrating experience for physicians and their patients.

Now, research at Johns Hopkins may help provide some answers to the puzzle.

By harvesting white blood cells from patients, placing the cells in tissue culture plates and exposing them to common steroid and immunosuppressant medications, scientists can predict in some cases what medications might work best for each patient.

If a patient's white blood cells are suppressed by the medications, it is hoped that the patient will respond favorably to treatment. By contrast, if the cells are insensitive to the medications, the test suggests that the traditional approach to treatment may be ineffective, and that either higher doses or more than one drug may be required.

An article on this research in the Journal of Clinical Pharmacology recently was selected by the American College of Clinical Pharmacology as the most promising article of the past year.

William A. Briggs, M.D., associate professor of nephrology, was principal investigator.

Briggs, of Timonium, Md., will be presented with the college's 1997 McKeen Cattell Memorial Award on September 18 in Phoenix at the association's 26th annual meeting. The award is named in memory of the late McKeen Cattell, first editor of the Journal of Clinical Pharmacology and co-founder of the college. It is presented annually to an author publishing an outstanding research paper in the journal.

"Individualizing treatment plans for patients is not a new idea in medicine, but this is the first time this notion has been applied to improve glomerular diseases," says Briggs. "A major problem in caring for these patients has been the lack of reliable clinical or laboratory techniques for estimating a favorable response to treatment. Although our work is preliminary, further refinement of this technique might contribute to improved treatment results."

The award-winning article describes how researchers studied 16 patients with various diseases of the glomerulus, a network of blood capillaries that filter waste products from the blood into the kidneys. They tested different combinations of glucocorticoids (steroids) and cyclosporine (a drug that suppresses the immune system) on patients' white blood cells in tissue plates, and found a wide range of responses among the patients. Therefore, they concluded that such tests might assist physicians in developing a treatment strategy for their individual patients.

Further work in this area by the Hopkins team on additional patients has shown that some patients -- who previously had not been helped much by medication -- have responded quickly to medications found effective in the assays. Others have been helped by a lower dose of medication than previously thought necessary.

More investigation still needs to be done on this technique, says Briggs, because these types of tests do not necessarily predict how the drugs will respond inside the body. Patients who wish to volunteer for the studies can call (410) 955-5268.
-end-

The paper's other authors were Zu-Hua Gao, M.D.; Luis F. Gimenez, M.D.; Paul J. Scheel, Jr., M.D.; Michael J. Choi, M.D.; and James F. Burdick, M.D.

Johns Hopkins Medicine

Related Medication Articles from Brightsurf:

New medication may treat underlying causes of hypertrophic cardiomyopathy
Mavacamten, a new investigational cardiac medication, may improve heart function for people with thickened heart muscle leading to obstructed blood flow through the heart, a condition known as obstructive hypertrophic cardiomyopathy.

Therapy plus medication better than medication alone in bipolar disorder
A review of 39 randomized clinical trials by scientists from UCLA and their colleagues from other institutions has found that combining the use medication with psychoeducational therapy is more effective at preventing a recurrence of illness in people with bipolar disorder than medication alone.

Kids diagnosed with ADHD often don't take medication regularly
Children diagnosed with ADHD inconsistently take their prescribed medication, going without treatment 40 per cent of the time, a new study has found.

Long-term medication for schizophrenia is safe
Researchers at Karolinska Institutet in Sweden and their colleagues in Germany, the USA and Finland have studied the safety of very long-term antipsychotic therapy for schizophrenia.

Which is more effective for treating PTSD: Medication, or psychotherapy?
A systematic review and meta-analysis led by Jeffrey Sonis, MD, MPH, of the University of North Carolina School of Medicine, finds there is insufficient evidence at present to answer that question.

ADHD medication: How much is too much for a hyperactive child?
When children with ADHD don't respond well to Methylphenidate (MPH, also known as Ritalin) doctors often increase the dose.

Pain medication use by children after common surgeries
About 400 caregivers reported pain medication use by children after common surgeries such as hernia, elbow fracture, appendectomy or adenoid removal in this study.

Bringing cancer medication safely to its destination
Treating cancer more selectively and more effectively -- this could be achieved with an innovative technology developed by teams of researchers at the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) and the Ludwig-Maximilians-Universität München (LMU).

Bullying linked to student's pain medication use
In a school-based survey study of all students in grades 6, 8, and 10 in Iceland, the use of pain medications was significantly higher among bullied students even when controlling for the amount of pain they felt, as well as age, gender, and socioeconomic status.

New medication gives mice bigger muscles
Researchers from Aarhus University, Denmark, have studied a new group of medicinal products which increase the muscle- and bone mass of mice over a few weeks.

Read More: Medication News and Medication Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.